HEADER TRANSFERASE 05-JUN-15 5BVW TITLE FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDEUS 576-894; COMPND 5 SYNONYM: EPITHELIAL DISCOIDIN DOMAIN RECEPTOR 1,CD167 ANTIGEN-LIKE COMPND 6 FAMILY MEMBER A,CELL ADHESION KINASE,DISCOIDIN RECEPTOR TYROSINE COMPND 7 KINASE,HGK2,MAMMARY CARCINOMA KINASE 10,MCK-10,PROTEIN-TYROSINE COMPND 8 KINASE 3A,PROTEIN-TYROSINE KINASE RTK-6,TRK E,TYROSINE KINASE DDR, COMPND 9 TYROSINE-PROTEIN KINASE CAK; COMPND 10 EC: 2.7.10.1; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS DDR1, FRAGMENTS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.MURRAY,V.BERDINI,I.BUCK,M.CARR,A.CLEASBY,J.COYLE,J.CURRY,J.DAY, AUTHOR 2 K.HEARN,A.IQBAL,L.LEE,V.MARTINS,P.MORTENSON,J.MUNCK,L.PAGE,S.PATEL, AUTHOR 3 S.ROOMANS,T.KIRSTEN,G.SAXTY REVDAT 1 05-AUG-15 5BVW 0 JRNL AUTH C.W.MURRAY,V.BERDINI,I.M.BUCK,M.E.CARR,A.CLEASBY,J.E.COYLE, JRNL AUTH 2 J.E.CURRY,J.E.DAY,P.J.DAY,K.HEARN,A.IQBAL,L.Y.LEE,V.MARTINS, JRNL AUTH 3 P.N.MORTENSON,J.M.MUNCK,L.W.PAGE,S.PATEL,S.ROOMANS,K.SMITH, JRNL AUTH 4 E.TAMANINI,G.SAXTY JRNL TITL FRAGMENT-BASED DISCOVERY OF POTENT AND SELECTIVE DDR1/2 JRNL TITL 2 INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 6 798 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26191369 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00143 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 2.11.6 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 25195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1266 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2212 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 287 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.55940 REMARK 3 B22 (A**2) : -3.15540 REMARK 3 B33 (A**2) : -1.40400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BVW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210625. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25196 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 33.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18.0%W/V PEG 3350, 0.2M NH4I, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.82100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.89350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.39000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.89350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.82100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.39000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 590 REMARK 465 ALA A 591 REMARK 465 MET A 592 REMARK 465 GLY A 593 REMARK 465 SER A 594 REMARK 465 ALA A 595 REMARK 465 VAL A 596 REMARK 465 GLY A 597 REMARK 465 ASP A 598 REMARK 465 GLY A 599 REMARK 465 PRO A 600 REMARK 465 PRO A 601 REMARK 465 ARG A 602 REMARK 465 VAL A 603 REMARK 465 PRO A 632 REMARK 465 GLN A 633 REMARK 465 ASP A 634 REMARK 465 LEU A 635 REMARK 465 VAL A 636 REMARK 465 SER A 637 REMARK 465 LEU A 638 REMARK 465 ASP A 639 REMARK 465 PHE A 640 REMARK 465 PRO A 641 REMARK 465 LEU A 642 REMARK 465 ASN A 643 REMARK 465 VAL A 644 REMARK 465 ARG A 645 REMARK 465 LYS A 646 REMARK 465 GLY A 647 REMARK 465 ALA A 722 REMARK 465 ALA A 723 REMARK 465 GLU A 724 REMARK 465 GLY A 725 REMARK 465 ALA A 726 REMARK 465 PRO A 727 REMARK 465 GLY A 728 REMARK 465 ASP A 729 REMARK 465 GLY A 730 REMARK 465 GLN A 731 REMARK 465 ALA A 732 REMARK 465 ALA A 733 REMARK 465 GLN A 734 REMARK 465 GLY A 735 REMARK 465 MET A 787 REMARK 465 SER A 788 REMARK 465 ARG A 789 REMARK 465 ASN A 790 REMARK 465 THR A 912 REMARK 465 VAL A 913 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 693 -104.94 -73.03 REMARK 500 ARG A 765 -12.24 73.51 REMARK 500 ASP A 766 49.85 -142.25 REMARK 500 PHE A 785 118.50 40.34 REMARK 500 GLU A 907 -65.87 -124.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1383 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH A1384 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH A1385 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A1386 DISTANCE = 6.84 ANGSTROMS REMARK 525 HOH A1387 DISTANCE = 7.14 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IOD A 1008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1N1 A 1009 DBREF 5BVW A 595 913 UNP Q08345 DDR1_HUMAN 576 894 SEQADV 5BVW GLY A 590 UNP Q08345 EXPRESSION TAG SEQADV 5BVW ALA A 591 UNP Q08345 EXPRESSION TAG SEQADV 5BVW MET A 592 UNP Q08345 EXPRESSION TAG SEQADV 5BVW GLY A 593 UNP Q08345 EXPRESSION TAG SEQADV 5BVW SER A 594 UNP Q08345 EXPRESSION TAG SEQRES 1 A 324 GLY ALA MET GLY SER ALA VAL GLY ASP GLY PRO PRO ARG SEQRES 2 A 324 VAL ASP PHE PRO ARG SER ARG LEU ARG PHE LYS GLU LYS SEQRES 3 A 324 LEU GLY GLU GLY GLN PHE GLY GLU VAL HIS LEU CYS GLU SEQRES 4 A 324 VAL ASP SER PRO GLN ASP LEU VAL SER LEU ASP PHE PRO SEQRES 5 A 324 LEU ASN VAL ARG LYS GLY HIS PRO LEU LEU VAL ALA VAL SEQRES 6 A 324 LYS ILE LEU ARG PRO ASP ALA THR LYS ASN ALA ARG ASN SEQRES 7 A 324 ASP PHE LEU LYS GLU VAL LYS ILE MET SER ARG LEU LYS SEQRES 8 A 324 ASP PRO ASN ILE ILE ARG LEU LEU GLY VAL CYS VAL GLN SEQRES 9 A 324 ASP ASP PRO LEU CYS MET ILE THR ASP TYR MET GLU ASN SEQRES 10 A 324 GLY ASP LEU ASN GLN PHE LEU SER ALA HIS GLN LEU GLU SEQRES 11 A 324 ASP LYS ALA ALA GLU GLY ALA PRO GLY ASP GLY GLN ALA SEQRES 12 A 324 ALA GLN GLY PRO THR ILE SER TYR PRO MET LEU LEU HIS SEQRES 13 A 324 VAL ALA ALA GLN ILE ALA SER GLY MET ARG TYR LEU ALA SEQRES 14 A 324 THR LEU ASN PHE VAL HIS ARG ASP LEU ALA THR ARG ASN SEQRES 15 A 324 CYS LEU VAL GLY GLU ASN PHE THR ILE LYS ILE ALA ASP SEQRES 16 A 324 PHE GLY MET SER ARG ASN LEU TYR ALA GLY ASP TYR TYR SEQRES 17 A 324 ARG VAL GLN GLY ARG ALA VAL LEU PRO ILE ARG TRP MET SEQRES 18 A 324 ALA TRP GLU CYS ILE LEU MET GLY LYS PHE THR THR ALA SEQRES 19 A 324 SER ASP VAL TRP ALA PHE GLY VAL THR LEU TRP GLU VAL SEQRES 20 A 324 LEU MET LEU CYS ARG ALA GLN PRO PHE GLY GLN LEU THR SEQRES 21 A 324 ASP GLU GLN VAL ILE GLU ASN ALA GLY GLU PHE PHE ARG SEQRES 22 A 324 ASP GLN GLY ARG GLN VAL TYR LEU SER ARG PRO PRO ALA SEQRES 23 A 324 CYS PRO GLN GLY LEU TYR GLU LEU MET LEU ARG CYS TRP SEQRES 24 A 324 SER ARG GLU SER GLU GLN ARG PRO PRO PHE SER GLN LEU SEQRES 25 A 324 HIS ARG PHE LEU ALA GLU ASP ALA LEU ASN THR VAL HET IOD A1001 1 HET IOD A1002 1 HET IOD A1003 1 HET IOD A1004 1 HET IOD A1005 1 HET IOD A1006 1 HET IOD A1007 1 HET IOD A1008 1 HET 1N1 A1009 33 HETNAM IOD IODIDE ION HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETSYN 1N1 DASATINIB FORMUL 2 IOD 8(I 1-) FORMUL 10 1N1 C22 H26 CL N7 O2 S FORMUL 11 HOH *287(H2 O) HELIX 1 AA1 PRO A 606 SER A 608 5 3 HELIX 2 AA2 THR A 662 ARG A 678 1 17 HELIX 3 AA3 ASP A 708 ALA A 715 1 8 HELIX 4 AA4 SER A 739 LEU A 760 1 22 HELIX 5 AA5 ALA A 768 ARG A 770 5 3 HELIX 6 AA6 GLU A 776 PHE A 778 5 3 HELIX 7 AA7 TYR A 792 TYR A 796 5 5 HELIX 8 AA8 PRO A 806 MET A 810 5 5 HELIX 9 AA9 ALA A 811 GLY A 818 1 8 HELIX 10 AB1 THR A 821 MET A 838 1 18 HELIX 11 AB2 THR A 849 ASP A 863 1 15 HELIX 12 AB3 PRO A 877 TRP A 888 1 12 HELIX 13 AB4 GLU A 891 ARG A 895 5 5 HELIX 14 AB5 PRO A 897 GLU A 907 1 11 HELIX 15 AB6 ASP A 908 ASN A 911 5 4 SHEET 1 AA1 5 LEU A 610 GLU A 618 0 SHEET 2 AA1 5 GLU A 623 VAL A 629 -1 O LEU A 626 N GLU A 614 SHEET 3 AA1 5 LEU A 650 ILE A 656 -1 O VAL A 652 N CYS A 627 SHEET 4 AA1 5 CYS A 698 ASP A 702 -1 O MET A 699 N LYS A 655 SHEET 5 AA1 5 LEU A 687 VAL A 690 -1 N LEU A 688 O ILE A 700 SHEET 1 AA2 2 GLN A 717 LEU A 718 0 SHEET 2 AA2 2 THR A 737 ILE A 738 1 O ILE A 738 N GLN A 717 SHEET 1 AA3 2 CYS A 772 VAL A 774 0 SHEET 2 AA3 2 ILE A 780 ILE A 782 -1 O LYS A 781 N LEU A 773 SSBOND 1 CYS A 691 CYS A 698 1555 1555 2.05 CISPEP 1 ASP A 604 PHE A 605 0 -13.87 CISPEP 2 ASP A 695 PRO A 696 0 -8.95 SITE 1 AC1 2 LEU A 883 ARG A 886 SITE 1 AC2 5 GLY A 619 GLN A 620 GLY A 622 LYS A 655 SITE 2 AC2 5 IOD A1008 SITE 1 AC3 3 ASP A 681 PRO A 682 ARG A 686 SITE 1 AC4 1 HIS A 902 SITE 1 AC5 2 PRO A 659 SER A 739 SITE 1 AC6 1 LEU A 718 SITE 1 AC7 2 GLY A 619 IOD A1003 SITE 1 AC8 13 LEU A 616 ALA A 653 LYS A 655 MET A 676 SITE 2 AC8 13 THR A 701 ASP A 702 TYR A 703 MET A 704 SITE 3 AC8 13 GLU A 705 GLY A 707 LEU A 773 ALA A 783 SITE 4 AC8 13 PHE A 785 CRYST1 61.642 72.780 75.787 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016223 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013740 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013195 0.00000